Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Knee Injury Cohort @ the Kennedy (KICK) study recruited its 142nd participant this week. Chief investigator Fiona Watt reports that the study has entered its final stages of recruitment – it aims tofollow 150 people with recent knee injuries over 5 years. 

Joint injury is a major risk factor for osteoarthritis, with about 50% of those with knee injuries developing the condition; this can be in their 30s or 40s if they have suffered sporting injuries whilst young. Work in the Kennedy Institute laboratories on the immediate effects of joint tissue injury has identified important markers of this response: the KICK study is testing whether measurement of this ‘joint injury response’ can predict the development of osteoarthritis in humans. The initial findings of the study were recently presented at the OARSI World Congress in Paris.

The KICK study is pioneering electronic collection of follow-up data – participants can simply click on an emailed link which allows them to input their answers to questionnaires directly and securely on to the study database. The study hopes to identify new tests to predict osteoarthritis, and targets for new medical treatments to slow or prevent the condition. It works closely with Andrew Williams, leading UK sports knee surgeon and other researchers in the newly-formed Arthritis Research UK Centre for Osteoarthritis Pathogenesis, based at the Kennedy Institute.

Similar stories

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

Exploring the link between joint injury and osteoarthritis

A new study published in The Lancet Rheumatology shows potential ways to predict how likely someone is to develop osteoarthritis after a knee injury.

Repurposed drug can induce remission of inflammatory arthritis

Researchers at the Kennedy Institute demonstrate that the drug decitabine can boost regulatory T cell responses.

Small mechanical forces in immune cells measured at unprecedented sensitivity

Oxford researchers have used advanced microscopy techniques to measure previously unseen forces generated by cells during an immune response; a breakthrough for mechanobiology and future advances in health and disease.

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

The University of Oxford has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Vascular loss shown to be the primary hallmark of aging

New Research from the Kusumbe group at the Kennedy Institute of Rheumatology identifies vascular attrition, marked by pericyte to fibroblast differentiation, as a primary hallmark of aging and highlights organ-specific vascular changes with age.